Error message

  • Deprecated function: Creation of dynamic property MergeQuery::$condition is deprecated in MergeQuery->__construct() (line 1357 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).
  • Deprecated function: Creation of dynamic property DatabaseCondition::$stringVersion is deprecated in DatabaseCondition->compile() (line 1887 of /home/topnewse/public_html/topnewsnl/includes/database/query.inc).

Cipla

Sudarshan Sukhani: BUY Titan, Cipla, UltraTech Cement; SELL Tata Steel

Sudarshan Sukhani: BUY Titan, Cipla, UltraTech Cement; SELL Tata Steel

Technical analyst Sudarshan Sukhani has suggested three BUY Calls and one SELL Call for today’s trading session.

Ashwani Gujral: BUY Cipla, Biocon; SELL Axis Bank, Bajaj Finance and Prestige Estate

Ashwani Gujral: BUY Cipla, Biocon; SELL Axis Bank, Bajaj Finance and Prestige Estate

Ashwani Gujral: BUY IndusInd Bank, SBI, Kotak Mahindra Bank, Sun Pharma and Godrej Consumer

Ashwani Gujral: BUY IndusInd Bank, SBI, Kotak Mahindra Bank, Sun Pharma and Godrej Consumer

Market analyst Ashwani Gujral has suggested five BUY Calls and no SELL calls for today’s trade, suggesting a bullish view for bounce-back in Indian markets after yesterday’s decline.

Ashwani Gujral: BUY Cipla, Dr Reddy’s, Tata Steel, UPL and Bharti Infratel

Ashwani Gujral: BUY Cipla, Dr Reddy’s, Tata Steel, UPL and Bharti Infratel

Market analyst Ashwani Gujral has suggested five BUY calls and no SELL call for today’s session, suggesting a bullish outlook for markets.

Sanjiv Bhasin IIFL Securities: Lupin, Cipla, IPCA Labs, Cadila and Dr Lal Path Labs look interesting

Sanjiv Bhasin IIFL Securities: Lupin, Cipla, IPCA Labs, Cadila and Dr Lal Path Labs look interesting

Market expert Sanjiv Bhasin has suggested five stocks for investors and medium-term outlook traders for August in the pharmaceutical segment.

Controversy about Gilead’s Remdesivir in India due to low production and black market sale

Controversy about Gilead’s Remdesivir in India due to low production and black market sale

Gilead Sciences signed a contract with four Indian pharmaceutical companies to produce its medication ‘Remdesivir’ which has been found effective in treatment of some COVID-19 patients.

Pages

Error | TopNews

Under Maintenance

The website encountered an unexpected error. Please try again later.